Novartis AG (NVS) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 6 Buy, 17 Hold, 2 Sell.
The consensus price target is $127.00 (low: $112.00, high: $143.00), representing a downside of 17.2% from the current price $153.38.
Analysts estimate Earnings Per Share (EPS) of $9.53 and revenue of $63.76B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $5.92 vs est $9.53 (missed -37.9%). 2025: actual $7.25 vs est $11.29 (missed -35.8%). Analyst accuracy: 42%.
NVS Stock — 12-Month Price Forecast
$127.00
▼ -17.20% Downside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Novartis AG, the average price target is $127.00, with a high forecast of $143.00, and a low forecast of $112.00.
The average price target represents a -17.20% change from the last price of $153.38.
Highest Price Target
$143.00
Average Price Target
$127.00
Lowest Price Target
$112.00
NVS Analyst Ratings
Hold
Based on 25 analysts giving stock ratings to Novartis AG in the past 3 months
EPS Estimates — NVS
42%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $5.92
vs Est $9.53
▼ 61.0% off
2025
Actual $7.25
vs Est $11.29
▼ 55.7% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — NVS
74%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $51.722B
vs Est $63.764B
▼ 23.3% off
2025
Actual $54.811B
vs Est $70.126B
▼ 27.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
